Naoko Kajitani

679 citations
24 papers · 540 indexed · h-index 14
Topics
Cervical Cancer and HPV Research (17 papers)RNA Research and Splicing (10 papers)Cancer-related molecular mechanisms research (8 papers)
Partner nations
SwedenChinaJapan

In The Last Decade

Naoko Kajitani

24 papers receiving 532 citations

Peers

Naoko Kajitani
Comparison fields: 5 of 63
  • Molecular Biology 266
  • Epidemiology 225
  • Immunology 186
  • Cancer Research 107
  • Oncology 87
Replace Edward S. Dornan with:
Edward S. Dornan United Kingdom
Heike E. Brand United States
Robert Jackson Canada
Sébastien Teissier Singapore
Louis Cicchini United States
Elizabeth Payne Australia
Wioleta Łuszczek Poland
Orit Berhani Israel
Nicholas A. Wallace United States
Y Tomita Japan
Naoko Kajitani relative to Edward S. Dornan United Kingdom Edward S. Dornan's profile →
Citations per field
00.5×3.1×
Edward S. Dornan · 1×
Citations per year

Countries citing papers authored by Naoko Kajitani

Since Specialization
Citations

This map shows the geographic impact of Naoko Kajitani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naoko Kajitani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naoko Kajitani more than expected).

Fields of papers citing papers by Naoko Kajitani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Naoko Kajitani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naoko Kajitani. The network helps show where Naoko Kajitani may publish in the future.

Co-authorship network of co-authors of Naoko Kajitani

This figure shows the co-authorship network connecting the top 25 collaborators of Naoko Kajitani. A scholar is included among the top collaborators of Naoko Kajitani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Naoko Kajitani. Naoko Kajitani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 2
3 5
4 18
5 13
6 11
7 5
8 7
9 9
10 2
11 27
12 28
13 30
14 18
15 129
16 4
17 101
18 5
19 23
20 25

About Naoko Kajitani

Naoko Kajitani is a scholar working on Cancer Research, Epidemiology and Virology, having authored 24 papers that have together received 540 indexed citations. Recurring topics across this work include Cervical Cancer and HPV Research (17 papers), RNA Research and Splicing (10 papers) and Cancer-related molecular mechanisms research (8 papers). The work is most often cited by research in Immunology (186 citations), Cancer Research (107 citations) and Epidemiology (225 citations). Naoko Kajitani has collaborated with scholars based in Sweden, China and Japan. Frequent co-authors include Stefan Schwartz, Ayano Satsuka, Hiroyuki Sakai, Chengjun Wu, Xiaoxu Cui, Ken Murakami, Hideyo Hirai, Satoshi Yoshida, Hidetaka Ishino and Eishi Ashihara. Their work appears in journals such as Nucleic Acids Research, Journal of Biological Chemistry and The Journal of Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026